Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing radioactive arsenic compound and usage for curing tumor

An arsenic compound and radioactive technology, applied in the direction of radioactive preparations, radioactive carriers, antineoplastic drugs, etc. in the body, can solve the problems not mentioned

Inactive Publication Date: 2009-07-01
TTY BIOPHARM
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this review paper does not address whether arsenic-containing compounds such as arsenic trioxide, arsenic trisulfide, and arsenic disulfide can be manufactured into therapeutic radiopharmaceuticals

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing radioactive arsenic compound and usage for curing tumor
  • Method for preparing radioactive arsenic compound and usage for curing tumor
  • Method for preparing radioactive arsenic compound and usage for curing tumor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Embodiment 1. Preparation of radioactive arsenic trioxide

[0069] Put 5 mg of arsenic trioxide powder (available from Taiwan Dongyang Pharmaceutical Company) into a quartz tube (Quartz glass, Tosiba, Japan), and the mouth of the quartz tube was completely sealed with a gas / oxygen mixed flame. The quartz tube was wrapped with aluminum foil and put into the irradiation target of a special aluminum tube for irradiation, and the neutron irradiation treatment was carried out for 30 hours under the operating conditions that would make the formed product have a radioactivity of 2-4mCi.

[0070] The irradiated quartz tube was cut with a cutting tool, and 3ml of 1N NaOH solution was added to the cut quartz tube to dissolve As 2 o 3 . After 20 minutes, 1 ml of 1N HCl solution was added, and finally 1 ml of normal saline was added to adjust the solution concentration to 1 mg / ml. The obtained solution containing arsenic trioxide irradiated with neutrons was subjected to gamm...

Embodiment 2

[0076] Example 2. Establishment of an animal model with liver tumors

[0077] Operation method:

[0078] The tumor cells used to establish the animal model with liver tumors were rat liver tumor cells purchased from the American Type Culture Collection (ATCC), P.O. Box 1549, Manassas, VA 20108, USA] Strain N1-S1 (rathepatoma cell line N1-S1), through continuous subculture to establish master cell bank and working cell bank.

[0079] Rat liver tumor cells N1-S1 are suspension cells, which were suspended in 1% penicillin (GibcoBRL ) with 10% fetal bovine serum (GibcoBRL ) of Iscove's Modified Dulbecco's Medium (IMDM) (GibcoBRL ), and at 5% CO 2 cultured in a constant temperature incubator at 37°C.

[0080] In culture to 1.5 x 10 6 Cells / ml, take out 4×10 6 Cells / 0.06ml of N1-S1 cells were surgically implanted between the liver and liver viscera capsule of male rats (Spawn Dawley, 5 weeks old, 150 g), and the wound was sutured. After continuing to feed the rats for 10 ...

Embodiment 3

[0089] Example 3. Biodistribution test (Biodistribution test)

[0090] Hepatic artery injection:

[0091] The hepatic artery and liver tissue of the rat were surgically stripped, and a PE-10 tube (PE-10 tube) was inserted into the hepatic artery, and then injected with the neutron-irradiated arsenic trioxide prepared in Example 1. After the injection, the PE-10 tube was drawn out, and the blood vessel was sealed and fixed with surgical thread, and then the wound was sutured.

[0092] Tail vein injection:

[0093]The test injection solution prepared in Example 1 containing arsenic trioxide treated with neutron irradiation was directly injected into the rat's tail vein with a syringe with a 25-gauge needle.

[0094] Operation method:

[0095] Rats suffering from liver tumors were injected with a certain amount of radioactive arsenic trioxide prepared in Example 1 through the hepatic artery and tail vein respectively (radioactive range is 2.77-3.25mCi / ml, concentration is 1mg / ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention provides a process for producing a radioactive arsenic-containing compound, comprising the steps of: (i) subjecting an arsenic-containing compound to a neutron irradiation treatment, said arsenic-containing compound being selected from a group consisting of As2O3, As2S3, As2S2, and a combination thereof, such that the arsenic element contained in the arsenic-containing compound is converted to a radioactive arsenic isotope; and (ii) recovering the resultant product from step (i). <??>This invention also provides a pharmaceutical composition comprising a therapeutically effective amount of the radioactive arsenic-containing compound and a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the treatment of tumors / cancers such as hematological malignancies and solid tumors. <IMAGE>

Description

technical field [0001] The present invention relates to a method for the preparation of a radioactive arsenic compound and the use of the radioactive arsenic compound for the treatment of tumors / cancers such as blood cancer or solid tumors. In particular, will be selected from arsenic trioxide (As 2 o 3 ), arsenic trisulfide (As 2 S 3 ), arsenic disulfide (As 2 S 2 ) and their combinations are subjected to neutron irradiation so that the arsenic element contained in the arsenic compound is converted into radioactive arsenic isotopes. The radioactive arsenic-containing compound can be formulated into a pharmaceutical composition for the treatment of tumors / cancers such as blood cancers or solid tumors. Background technique [0002] Tumor / cancer has always been a threat to human health. Over the years, the medical community has devoted itself to developing effective drugs for the treatment of tumors / cancers. However, currently, there is no drug that can effectively tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K51/00A61P35/00A61K101/00A61K33/36A61K51/02
CPCA61K33/36A61K51/02A61P35/00
Inventor 李德伟黄纯莹吴明烜陈德容张国平张湘戎祈式仪张志贤许银茂范国贤徐维荃傅应凯高长风
Owner TTY BIOPHARM